Pharming Group reopens EMEA’s CB market

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity-Linked

Pharming Group reopens EMEA’s CB market

Aidan Gregory
January 14, 2020 02:00 PM
Pharming_PA_230x150
Pharmaceuticals being produced at the company STADA Azneimittel AG in Bad Vilbel, Germany, 20 June 2016. STADA specialised on the production of generic medicaments and over-the-counter pharmaceuticals for pharmacies. PHOTO: FRANK RUMPENHORST/dpa | Frank Rumpenhorst/DPA/PA Images

Europe’s primary equity-linked market has reopened, with a new €125m convertible bond from Pharming Group, the Dutch speciality pharmaceuticals company.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganHealth and BiotechThe NetherlandsEquityEuropeEMEASRIEquity-Linked
AG
Aidan Gregory
Gift this article